Co-founder, Director, and President and Chief Business Officer, Equillium
Bruce is a co-founder, Director, and President and Chief Business Officer of Equillium. He is also the founder and Managing Director of BioMed Ventures, the strategic investment arm of BioMed Realty. Since founding BioMed Ventures, Bruce has directed investments in over 30 biotechnology companies including Auspex, AnaptysBio, NeoTract and Receptos. Prior to co-founding Equillium, Bruce was co-founder and CEO of Rincon Pharmaceuticals, a genetic engineering biotechnology company, until its acquisition in 2008; previously he was Chief Business Officer at Anaphore and Head of Corporate Development at Ambit Biosciences. Bruce serves on the Board of Directors of Breathe Technologies and Aegea Medical, and is a board observer for a number of other private companies.
From idea inception to commercialization, more and more start-ups are looking to large companies for strategic partnerships. This panel will explore the fundamental aspects needed to forge mutually beneficial relationships with large partners, such as collaborations, investments, licensing opportunities and in some cases M&A. Seasoned executives will share their perspective on the importance of relationships […]